Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Manufacturing: SOP for Documentation of In-Process Observations – V 2.0

Posted on By

Manufacturing: SOP for Documentation of In-Process Observations – V 2.0

Standard Operating Procedure for Documentation of In-Process Observations


Department Manufacturing
SOP No. SOP/MFG/178/2025
Supersedes SOP/MFG/178/2022
Page No. Page 1 of 12
Issue Date 24/06/2025
Effective Date 25/06/2025
Review Date 24/06/2026

1. Purpose

This SOP outlines the process for documenting all in-process observations made during the manufacturing of sterile injectable products. Proper documentation ensures product traceability, deviation identification, and compliance with GMP and data integrity standards.

2. Scope

This SOP applies to all production areas involved in the sterile injectable manufacturing process including

solution preparation, filtration, filling, lyophilization, sealing, and packaging stages where critical observations are required.

3. Responsibilities

  • Production Operator: To make real-time entries of observed parameters and any events during processing.
  • Shift Supervisor: To verify entries and review for any anomalies or missing data.
  • Quality Assurance (QA): To audit and evaluate documentation accuracy and integrity.

4. Accountability

Head of Manufacturing shall be accountable for ensuring adherence to this SOP and timely review of all in-process observation records.

See also  Sterile Injectable Manufacturing: SOP for Real-Time Monitoring of Critical Process Parameters - V 2.0

5. Procedure

5.1 Documentation Standards

  1. All entries must be made using a permanent blue or black ball pen.
  2. Entries must be made at the time of activity (contemporaneous).
  3. Do not leave blank spaces. Cross out unused lines with a single stroke and initial.
  4. Corrections must follow ALCOA+ principles:
    • Draw a single line through the incorrect entry.
    • Write the correct entry above or next to it.
    • Initial, date, and provide justification.
  5. Use standard templates as mentioned in Annexure-1 and Annexure-2.

5.2 Types of Observations to be Recorded

  1. Visual Observations:
    • Clarity of solution
    • Presence of particulate matter
    • Foaming, color changes, crystallization
  2. Process Observations:
    • Pressure differentials
    • Fill volume and weight variations
    • Sealing parameters (temperature, vacuum levels)
  3. Environmental Conditions:
    • Temperature and RH inside filling zone
    • Grade-A area monitoring status

5.3 Real-Time Recording

  1. Observations shall be noted in the In-Process Observation Log (Annexure-1) during each stage.
  2. Wherever automated data is collected (e.g., SCADA), manual confirmation or annotations shall be made.
  3. Entries must reflect:
    • Batch number
    • Stage of processing
    • Time of observation
    • Operator initials
See also  Sterile Injectable Manufacturing: SOP for Cleaning and Maintenance of HEPA Filters in Cleanrooms - V 2.0

5.4 Handling Abnormal Observations

  1. Any out-of-trend (OOT) or unusual observation must be immediately reported to the supervisor.
  2. Supervisor to evaluate and escalate to QA, if needed.
  3. Deviations must be documented in the Observation Deviation Form (Annexure-2).
  4. Follow SOP for deviation handling if required.

5.5 Review and Control

  1. All observation logs to be reviewed by QA within 24 hours of batch completion.
  2. QA shall ensure completeness, legibility, and data integrity.
  3. Logs to be archived in Batch Production Record (BPR) file.

5.6 Data Integrity Guidelines

  1. All data must be Attributable, Legible, Contemporaneous, Original, and Accurate (ALCOA).
  2. Avoid use of correction fluid or overwriting.
  3. Sign and date each entry with full name or employee code.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BPR: Batch Production Record
  • OOT: Out-of-Trend
  • QA: Quality Assurance
  • ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate
See also  Sterile Injectable Manufacturing: SOP for Handling Deviations in Manufacturing Stages - V 2.0

7. Documents

  1. In-Process Observation Log – Annexure-1
  2. Observation Deviation Form – Annexure-2

8. References

  • WHO TRS 1019 Annex 4 – GMP for sterile products
  • MHRA GxP Data Integrity Guidance
  • ICH Q7 – Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: In-Process Observation Log

Date Batch No. Stage Observation Time Initials
24/06/2025 BN-239A Filling No foam observed, clear solution 10:30 AM SK

Annexure-2: Observation Deviation Form

Date Batch No. Stage Description of Deviation Immediate Action QA Reviewed
23/06/2025 BN-238C Solution Prep Particulate matter observed in solution Solution filtered again Yes

Revision History:

Revision Date Revision No. Details Reason Approved By
01/02/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Updated format and annexures Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Analytical Method Development: SOP for Assay Method Development for Topical Formulations – V 2.0
Next Post: Addressing Oversight Failures in Third-Party SOP Compliance

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version